Chinese Journal of Antituberculosis ›› 2019, Vol. 41 ›› Issue (2): 156-161.doi: 10.3969/j.issn.1000-6621.2019.02.007
• Original Articles • Previous Articles Next Articles
Zhi-hua CAO(),Yue-zhu ZHAO,Shuang-shuang HU
Received:
2018-11-19
Online:
2019-02-10
Published:
2019-02-01
Contact:
Zhi-hua CAO
E-mail:3035660368@qq.com
Zhi-hua CAO,Yue-zhu ZHAO,Shuang-shuang HU. Detection of drug resistance mutations in Mycobacterium tuberculosis to five antitubercular drugs using the fluorescent PCR probe melting curve method[J]. Chinese Journal of Antituberculosis, 2019, 41(2): 156-161. doi: 10.3969/j.issn.1000-6621.2019.02.007
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2019.02.007
[1] |
Zumla A, George A, Sharma V , et al. The WHO 2014 Global tuberculosis report—further to go. Lancet Glob Health, 2015,3(1):e10-12.
doi: 10.1016/S2214-109X(14)70361-4 URL |
[2] |
Gandhi NR, Nunn P, Dheda K , et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet, 2010,375(9728):1830-1843.
doi: 10.1016/S0140-6736(10)60410-2 URL |
[3] |
Zignol M, Hosseini MS, Wright A , et al. Global incidence of multidrug-resistant tuberculosis. J Infect Dis, 2006,194(8):479-485.
doi: 10.1086/jid.2006.194.issue-4 URL |
[4] | Caminero JA . Multidrug-resistant tuberculosis: epidemiology, risk factors and case finding. Int J Tuberc Lung Dis, 2010,14(4):382-390. |
[5] |
Cox H, Hughes J, Black J , et al. Precision medicine for drug-resistant tuberculosis in high-burden countries: is individualised treatment desirable and feasible. Lancet Infect Dis, 2018,18(9):e282-e287
doi: 10.1016/S1473-3099(18)30104-X URL |
[6] | 谭家莉 . 耐药结核病的防治现状及有效对策. 医药前沿, 2014(36):56-56. |
[7] | 沈欣, 宋沈超, 雷世光 . 耐药结核病流行现状及防控对策. 职业与健康, 2017,33(4):566-568. |
[8] | 杜娟 . 严重耐多药结核病的流行现状、防控难点及对策. 医学研究杂志, 2010,39(8):17-21. |
[9] |
Zhang Z, Wang Y, Pang Y , et al. Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2014,58(9):5632-5635.
doi: 10.1128/AAC.02778-14 URL |
[10] | 武洁, 桂晓虹, 李静 , 等. 比例法与绝对浓度法检测结核分枝杆菌药敏试验的比较. 中华检验医学杂志, 2011,34(2):137-138. |
[11] | Palomino JC . Molecular detection, identification and drug resistance detection in Mycobacterium tuberculosis. FEMS Immunol Med Microbiol, 2013,56(2):103-111. |
[12] |
Ioannidis P, Papaventsis D, Karabela S , et al. Cepheid GeneXpert MTB/RIF assay for Mycobacterium tuberculosis detection and rifampin resistance identification in patients with substantial clinical indications of tuberculosis and smear-negative microscopy results. J Clin Microbiol, 2011,49(8):3068-3070.
doi: 10.1128/JCM.00718-11 URL |
[13] | 张明霞, 代友超 . 耐多药结核病检测技术研究进展. 中国热带医学, 2017,17(3):312-316. |
[14] | 徐费凡, 顾德林, 瞿梅 , 等. 荧光PCR溶解曲线法快速检测结核分枝杆菌对利福平和异烟肼的耐药突变. 热带医学杂志, 2016,16(6):722-724. |
[15] | 刘靖元, 李仁龙, 徐亚军 . 应用单链探针反向杂交试验检测结核分枝杆菌耐药性分析. 中国医药科学, 2012,2(13):26-28. |
[16] | 姚春艳, 张立群, 府伟灵 . 应用基因芯片技术检测结核分枝杆菌耐药基因. 中华医院感染学杂志, 2010,20(11):1501-1504. |
[17] | 李兰, 郭述良, 罗永艾 . 结核病发病机制的研究进展. 中华结核和呼吸杂志, 2009,32(8):620-622. |
[18] | 中国防痨协会基础专业委员会. 结核病诊断实验室检验规程.北京: 中国教育文化出版社, 2006. |
[19] | Antonova AV, Gryadunov DA, Zimenkov DV . Molecular mechanisms of drug tolerance in Mycobacterium tuberculosis. Mol Biol (Mosk), 2018,52(3):435-450. |
[20] |
Trauner A, Liu Q, Via LE , et al. The within-host population dynamics of Mycobacterium tuberculosis, vary with treatment efficacy. Genome Biol, 2017,18(1):71.
doi: 10.1186/s13059-017-1196-0 URL |
[21] | World Health Organization . Global tuberculosis report 2017. Geneva:World Heallth Organization, 2017. |
[22] |
Lempens P, Meehan CJ, Vandelannoote K , et al. Isoniazid resistance levels of Mycobacterium tuberculosis can largely be predicted by high-confidence resistance-conferring mutations. Sci Rep, 2018,8(1):3246.
doi: 10.1038/s41598-018-21378-x URL |
[23] |
McGrath M, Gey van Pittius NC, van Helden PD , et al. Mutation rate and the emergence of drug resistance in Mycobacterium tuberculosis. J Antimicrob Chemother, 2014,69(2):292-302.
doi: 10.1093/jac/dkt364 URL |
[24] |
Fenner L, Egger M, Bodmer T , et al. Effect of mutation and genetic background on drug resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother, 2012,56(6):3047-3053.
doi: 10.1128/AAC.06460-11 URL |
[25] | Al-mutairi NM, Ahmad S, Mokaddas E . Performance compari-son of four methods for detecting multidrug-resistant Mycobacterium tuberculosis strains. Int J Tuberc Lung Dis, 2011,15(1):110-115. |
[26] | Moon HW, Hur M, Kim JY , et al. Comparison of three molecular assays for the detection of Rifampin resistance in Mycobacterium tuberculosis. J Clin Lab Anal, 2015,53(9):3032-3034. |
[27] | 张太松, 李明 . 分子诊断技术在耐多药结核分枝杆菌检测中的应用进展. 分子诊断与治疗杂志, 2009,1(2):129-134. |
[28] |
Elenitoba-Johnson KSJ, Bohling SD, Wittwer CT , et al. Multiplex PCR by multicolor fluorimetry and fluorescence melting curve analysis. Nat Med, 2001,7(2):249-253.
doi: 10.1038/84708 URL |
[29] | 马艳艳, 李辉, 赵东阳 , 等. 荧光PCR探针熔解曲线法检测结核分枝杆菌耐利福平突变研究. 中国国境卫生检疫杂志, 2011,34(6):451-454. |
[30] | 严虹, 施旭东, 胡春梅 , 等. 探针熔解曲线法快速检测结核分枝杆菌利福平、异烟肼、乙胺丁醇及链霉素耐药突变. 临床检验杂志, 2015,33(10):729-733. |
[31] | 李国利, 李庆阁, 王倩 , 等. PCR-探针熔解分析法检测结核分枝杆菌氟喹诺酮耐药基因突变的临床应用评价. 中华临床医师杂志(电子版), 2011,5(16):4641-4645. |
[1] | LI Ai-fang, CUI Xiao-li, KANG Lei, LEI Jing, DANG Li-yun, YANG Han. Value of fluorescence PCR probe melting curve method in detecting resistance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 998-1001. |
[2] | CHEN Feng-fang, MA Jun, HUANG Jin, YIN Hong-yun, SHA Wei, YANG Guang-hong, FENG Yong-hong. Preliminary study on establishing the diagnostic model for smear negative tuberculosis and stage Ⅰ/Ⅱ sarcoidosis with hilar/mediastinal lymphadenopathy and positive T-SPOT.TB results [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 832-837. |
[3] | DUAN Li-ming, DING Chao, LIU Yu-gang, WEI Lin, GU Zhen-ning. Application value of video-assisted thoracoscopic surgery in the treatment of chronic tuberculous empyema [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 850-853. |
[4] | SUN Qing, HUANG Hai-rong, WANG Gui-rong. In vitro activities and drug resistance mechanisms of bedaquiline, clofazimine and delamanid against common pathogenic non-tuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 880-884. |
[5] | SONG Yi-meng, LI Yuan-chun, HE Wen-cong, HE Ping, BAO Jing-jing, LIU Chun-fa, LIU Dong-xin, WANG Xin-yang, ZHAO Yan-lin, LI Yan-ming. Cost analysis of fluorescence PCR probe melting curve technique for the detection of Mycobacterium tuberculosis resistance in China [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 712-717. |
[6] | BAO Xun-di, JIANG Yue, LIANG Suo, CHENG Hong-yan, XIA Guang-xiu, WANG Chao, YE Qian, WANG Shu, WANG Qing. Analysis of the clinical isolation rate, population distribution and drug resistance of non-tuberculous mycobacteria in Anhui [J]. Chinese Journal of Antituberculosis, 2020, 42(7): 718-724. |
[7] | MA Jin-bao, REN Fei, ZENG Ling-cheng, CHEN Ming-wei. Analysis of drug susceptibility of 680 patients with multidrug-resistant tuberculosis in Xi’an City from 2015 to 2019 [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 609-613. |
[8] | QIN Zhong-hua, JING Ye, DU Yan-qing, SONG Xiao-mei, ZHANG Li-xia. Spectrum and drug resistance analysis of 339 strains of nontuberculous mycobacterium isolated from clinical practice [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 630-633. |
[9] | ZHANG Jing, CHEN Xi, WANG Bin, FU Lei, LU Yu, CHEN Xiao-you. Establishment of modified propidium monoazide (PMAxx)-quantitative PCR assay and its application for identification of antituberculosis drug activity [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 472-480. |
[10] | YANG Han,YANG Jing-fen,WU Hao,CUI Xiao-li,DANG Li-yun. Value of MicroDST test in detecting sensitivity of first-line anti-tuberculosis drugs [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 380-384. |
[11] | JIAN Yi-luan,WU Long-zhang,GU Zhuo-yun. Clinical characteristics and treatment outcomes of 18 patients with non-tuberculosis mycobacteria concerning eyes, ears, nose and throat [J]. Chinese Journal of Antituberculosis, 2020, 42(3): 255-258. |
[12] | CHEN Zhen-hua,LIU Bin-bin,CHEN Zhong-nan,TAN Yun-hong. Establishment and preliminary evaluation of a diagnostic model for the new patients with pathogen-negative pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(3): 266-271. |
[13] | CHEN Yan-mei,HUANG Xin-chun,SUN Qi,ZHANG Chen-chen,WEN Wen-pei,CHEN Liang. Analysis of drug resistance in patients with smear-negative and culture-positive pulmonary tuberculosis in Guangdong province in 2016 [J]. Chinese Journal of Antituberculosis, 2020, 42(3): 272-275. |
[14] | MA Gai-xia,TIAN Li-ming,WANG Yu,QIU Lei,XUE Ling-na,LU Zhen-hui,ZHANG Hui-yong,GUO Xiao-yan. Systematic evaluation and meta-analysis of integrated traditional Chinese and western medicine in the treatment of MDR-PTB [J]. Chinese Journal of Antituberculosis, 2020, 42(2): 95-100. |
[15] | YU Jia-jia, ZHANG Xu-xia, ZHANG Yu-qing, REN Wei-cong, YAO Cong, LI Chuan-you, LIU Yi, TANG Shen-jie. Preliminary study on detection method of MTB DNA by PCR amplification combined with CRISPR-Cas13a system [J]. Chinese Journal of Antituberculosis, 2020, 42(12): 1280-1288. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||